Warning letter
PCP LV LLC dba Pinnacle Compounding Pharmacy: warning letter of May 23, 2016
FDA warning letter 492707 · San Francisco District Office
Key facts
| Reference number | 492707 |
|---|---|
| Company | PCP LV LLC dba Pinnacle Compounding Pharmacy |
| Subject | CGMP/Compounded Drugs/Adulterated |
| Issue date | May 23, 2016 |
| Posted date | May 23, 2016 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| CFR sections cited | 211.42(c)(10)(iii), 201.115, 211.28(a), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b), 211.167(a), 211.137(a) |
| Inspection city | Las Vegas |
| Inspection ZIP | 89119 |
| Inspection start date | Jul 27, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: